{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:31:11Z","timestamp":1787502671810,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00345-017-2043-3","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T01:52:56Z","timestamp":1493776376000},"page":"1681-1688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2592-4755","authenticated-orcid":false,"given":"Michael","family":"Seitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaela","family":"Waidelich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Tilki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"issue":"6","key":"2043_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.eururo.2010.08.041","volume":"58","author":"FK Chun","year":"2010","unstructured":"Chun FK, Epstein JI, Ficarra V, Freedland SJ, Montironi R, Montorsi F, Shariat SF, Schroder FH, Scattoni V (2010) Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature. Eur Urol 58(6):851\u2013864. doi: 10.1016\/j.eururo.2010.08.041","journal-title":"Eur Urol"},{"issue":"3","key":"2043_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","volume":"63","author":"FM Wagenlehner","year":"2013","unstructured":"Wagenlehner FM, van Oostrum E, Tenke P, Tandogdu Z, Cek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE, GPIU investigators (2013) Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 63(3):521\u2013527. doi: 10.1016\/j.eururo.2012.06.003","journal-title":"Eur Urol"},{"issue":"5","key":"2043_CR3","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","volume":"186","author":"S Loeb","year":"2011","unstructured":"Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM (2011) Complications after prostate biopsy: data from SEER-medicare. J Urol 186(5):1830\u20131834. doi: 10.1016\/j.juro.2011.06.057","journal-title":"J Urol"},{"issue":"2","key":"2043_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/aja.2011.130","volume":"14","author":"PF Shen","year":"2012","unstructured":"Shen PF, Zhu YC, Wei WR, Li YZ, Yang J, Li YT, Li DM, Wang J, Zeng H (2012) The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis. Asian J Androl 14(2):310\u2013315. doi: 10.1038\/aja.2011.130","journal-title":"Asian J Androl"},{"issue":"2","key":"2043_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/sj.pcan.4500985","volume":"11","author":"A Takenaka","year":"2008","unstructured":"Takenaka A, Hara R, Ishimura T, Fujii T, Jo Y, Nagai A, Fujisawa M (2008) A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy. Prostate Cancer Prostatic Dis 11(2):134\u2013138. doi: 10.1038\/sj.pcan.4500985","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"2043_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4111\/icu.2016.57.2.94","volume":"57","author":"L Toner","year":"2016","unstructured":"Toner L, Bolton DM, Lawrentschuk N (2016) Prevention of sepsis prior to prostate biopsy. Investig Clin Urol 57(2):94\u201399. doi: 10.4111\/icu.2016.57.2.94","journal-title":"Investig Clin Urol"},{"issue":"3","key":"2043_CR7","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-5347(01)65680-5","volume":"156","author":"BF Schwartz","year":"1996","unstructured":"Schwartz BF, Swanzy S, Thrasher JB (1996) A randomized prospective comparison of antibiotic tissue levels in the corpora cavernosa of patients undergoing penile prosthesis implantation using gentamicin plus cefazolin versus an oral fluoroquinolone for prophylaxis. J Urol 156(3):991\u2013994","journal-title":"J Urol"},{"issue":"Suppl 3","key":"2043_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003495-199300453-00005","volume":"45","author":"E Cambau","year":"1993","unstructured":"Cambau E, Gutmann L (1993) Mechanisms of resistance to quinolones. Drugs 45(Suppl 3):15\u201323","journal-title":"Drugs"},{"issue":"2","key":"2043_CR9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/AAC.40.2.503","volume":"40","author":"J Carratala","year":"1996","unstructured":"Carratala J, Fernandez-Sevilla A, Tubau F, Dominguez MA, Gudiol F (1996) Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob Agents Chemother 40(2):503\u2013505","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2043_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.juro.2014.07.086","volume":"193","author":"F Bruyere","year":"2015","unstructured":"Bruyere F, Malavaud S, Bertrand P, Decock A, Cariou G, Doublet JD, Bernard L, Bugel H, Conquy S, Sotto A, Boiteux JP, Pogu B, Rebillard X, Mongiat-Artus P, Coloby P (2015) Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy. J Urol 193(1):145\u2013150. doi: 10.1016\/j.juro.2014.07.086","journal-title":"J Urol"},{"issue":"3","key":"2043_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","volume":"62","author":"A Carignan","year":"2012","unstructured":"Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, Pepin J (2012) Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol 62(3):453\u2013459. doi: 10.1016\/j.eururo.2012.04.044","journal-title":"Eur Urol"},{"key":"2043_CR12","doi-asserted-by":"publisher","unstructured":"Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH, Loblaw DA, Trachtenberg J, Stanimirovic A, Simor AE, Seth A, Urbach DR, Narod SA (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189 (1 Suppl):S12-17; discussion S17-18. doi: 10.1016\/j.juro.2012.11.015","DOI":"10.1016\/j.juro.2012.11.015"},{"issue":"10","key":"2043_CR13","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/jac\/dkt188","volume":"68","author":"D Batura","year":"2013","unstructured":"Batura D, Gopal Rao G (2013) The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention\u2013authors\u2019 response. J Antimicrob Chemother 68(10):2419\u20132420. doi: 10.1093\/jac\/dkt188","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2043_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1179\/1973947815Y.0000000001","volume":"28","author":"O Kandemir","year":"2016","unstructured":"Kandemir O, Bozlu M, Efesoy O, Guntekin O, Tek M, Akbay E (2016) The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients. J Chemother 28(4):284\u2013288. doi: 10.1179\/1973947815Y.0000000001","journal-title":"J Chemother"},{"issue":"1","key":"2043_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1464-410X.2007.06848.x","volume":"100","author":"AJ Schaeffer","year":"2007","unstructured":"Schaeffer AJ, Montorsi F, Scattoni V, Perroncel R, Song J, Haverstock DC, Pertel PE (2007) Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate. BJU Int 100(1):51\u201357. doi: 10.1111\/j.1464-410X.2007.06848.x","journal-title":"BJU Int"},{"issue":"2","key":"2043_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","volume":"65","author":"A Heidenreich","year":"2014","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N, European Association of U (2014) EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 65(2):467\u2013479. doi: 10.1016\/j.eururo.2013.11.002","journal-title":"Eur Urol"},{"issue":"1","key":"2043_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","volume":"65","author":"A Heidenreich","year":"2014","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N, European Association of U (2014) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65(1):124\u2013137. doi: 10.1016\/j.eururo.2013.09.046","journal-title":"Eur Urol"},{"issue":"1","key":"2043_CR18","first-page":"2533","volume":"13","author":"Y Miyazaki","year":"2016","unstructured":"Miyazaki Y, Akamatsu S, Kanamaru S, Kamiyama Y, Sengiku A, Iguchi R, Sano T, Takahashi A, Ito M, Takenawa J, Ito N, Ogura K (2016) A prospective randomized trial comparing a combined regimen of amikacin and levofloxacin to levofloxacin alone as prophylaxis in transrectal prostate needle biopsy. Urol J 13(1):2533\u20132540","journal-title":"Urol J"},{"key":"2043_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1867-6","author":"T Cai","year":"2016","unstructured":"Cai T, Gallelli L, Cocci A, Tiscione D, Verze P, Lanciotti M, Vanacore D, Rizzo M, Gacci M, Saleh O, Malossini G, Liguori G, Trombetta C, Rocco D, Palmieri A, Bartoletti R, Carini M, Wagenlehner FM, Naber K, Mirone V, Bjerklund Johansen TE (2016) Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative. World J Urol. doi: 10.1007\/s00345-016-1867-6","journal-title":"World J Urol"},{"issue":"6","key":"2043_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.acuro.2014.01.002","volume":"38","author":"F Lista","year":"2014","unstructured":"Lista F, Redondo C, Meilan E, Garcia-Tello A, Ramon de Fata F, Angulo JC (2014) Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin. Actas Urol Esp 38(6):391\u2013396. doi: 10.1016\/j.acuro.2014.01.002","journal-title":"Actas Urol Esp"},{"issue":"11","key":"2043_CR21","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s00345-016-1800-z","volume":"34","author":"M Samarinas","year":"2016","unstructured":"Samarinas M, Dimitropoulos K, Zachos I, Gravas S, Karatzas A, Tzortzis V (2016) A single dose of meropenem is superior to ciprofloxacin in preventing infections after transrectal ultrasound-guided prostate biopsies in the era of quinolone resistance. World J Urol 34(11):1555\u20131559. doi: 10.1007\/s00345-016-1800-z","journal-title":"World J Urol"},{"issue":"4","key":"2043_CR22","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.urology.2013.12.039","volume":"83","author":"J Shakil","year":"2014","unstructured":"Shakil J, Piracha N, Prasad N, Kopacz J, Tarasuk A, Farrell R, Urban C, Mariano N, Wang G, Segal-Maurer S (2014) Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization. Urology 83(4):710\u2013713. doi: 10.1016\/j.urology.2013.12.039","journal-title":"Urology"},{"issue":"6","key":"2043_CR23","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.juro.2015.06.075","volume":"194","author":"DA Barocas","year":"2015","unstructured":"Barocas DA, Mallin K, Graves AJ, Penson DF, Palis B, Winchester DP, Chang SS (2015) Effect of the USPSTF grade D recommendation against screening for prostate cancer on incident prostate cancer diagnoses in the United States. J Urol 194(6):1587\u20131593. doi: 10.1016\/j.juro.2015.06.075","journal-title":"J Urol"},{"issue":"5","key":"2043_CR24","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.juro.2013.04.134","volume":"190","author":"MM Issa","year":"2013","unstructured":"Issa MM, Al-Qassab UA, Hall J, Ritenour CW, Petros JA, Sullivan JW (2013) Formalin disinfection of biopsy needle minimizes the risk of sepsis following prostate biopsy. J Urol 190(5):1769\u20131775. doi: 10.1016\/j.juro.2013.04.134","journal-title":"J Urol"},{"key":"2043_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006576.pub2","author":"EL Zani","year":"2011","unstructured":"Zani EL, Clark OA, Rodrigues Netto N Jr (2011) Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev. doi: 10.1002\/14651858.CD006576.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2043_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/sur.2013.138","volume":"15","author":"DS Park","year":"2014","unstructured":"Park DS, Hwang JH, Choi DK, Gong IH, Hong YK, Park S, Oh JJ (2014) Control of infective complications of transrectal prostate biopsy. Surg Infect 15(4):431\u2013436. doi: 10.1089\/sur.2013.138","journal-title":"Surg Infect"},{"issue":"4","key":"2043_CR27","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.juro.2012.09.121","volume":"189","author":"Z Abughosh","year":"2013","unstructured":"Abughosh Z, Margolick J, Goldenberg SL, Taylor SA, Afshar K, Bell R, Lange D, Bowie WR, Roscoe D, Machan L, Black PC (2013) A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol 189(4):1326\u20131331. doi: 10.1016\/j.juro.2012.09.121","journal-title":"J Urol"},{"issue":"1","key":"2043_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.urology.2014.09.035","volume":"85","author":"J Dai","year":"2015","unstructured":"Dai J, Leone A, Mermel L, Hwang K, Pareek G, Schiff S, Golijanin D, Renzulli JF 2nd (2015) Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study. Urology 85(1):8\u201314. doi: 10.1016\/j.urology.2014.09.035","journal-title":"Urology"},{"issue":"4","key":"2043_CR29","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.juro.2011.11.115","volume":"187","author":"AK Taylor","year":"2012","unstructured":"Taylor AK, Zembower TR, Nadler RB, Scheetz MH, Cashy JP, Bowen D, Murphy AB, Dielubanza E, Schaeffer AJ (2012) Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 187(4):1275\u20131279. doi: 10.1016\/j.juro.2011.11.115","journal-title":"J Urol"},{"issue":"2","key":"2043_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.juro.2015.03.126","volume":"194","author":"PR Womble","year":"2015","unstructured":"Womble PR, Linsell SM, Gao Y, Ye Z, Montie JE, Gandhi TN, Lane BR, Burks FN, Miller DC, Improvement Michigan Urological Surgery, Michigan Urological Surgery Improvement Collaborative (2015) A statewide intervention to reduce hospitalizations after prostate biopsy. J Urol 194(2):403\u2013409. doi: 10.1016\/j.juro.2015.03.126","journal-title":"J Urol"},{"issue":"8","key":"2043_CR31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s11255-016-1299-7","volume":"48","author":"L Yang","year":"2016","unstructured":"Yang L, Tang Z, Gao L, Li T, Chen Y, Liu L, Han P, Li X, Dong Q, Wei Q (2016) The augmented prophylactic antibiotic could be more efficacious in patients undergoing transrectal prostate biopsy: a systematic review and meta-analysis. Int Urol Nephrol 48(8):1197\u20131207. doi: 10.1007\/s11255-016-1299-7","journal-title":"Int Urol Nephrol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-017-2043-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-017-2043-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-017-2043-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T21:07:26Z","timestamp":1569186446000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-017-2043-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["2043"],"URL":"https:\/\/doi.org\/10.1007\/s00345-017-2043-3","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]}}}